Capital International’s Core Laboratories CLB Stock Holding History

Capital International’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,709	Closed	-$89K	–	139
2019 Q2	$89K	Sell	1,709 -423	-20%	-$24.8K	0.02%	134
2019 Q1	$147K	Sell	2,132 -1,008	-32%	-$67.6K	0.04%	131
2018 Q4	$187K	Buy	3,140 +97	+3%	+$8.37K	0.05%	126
2018 Q3	$352K	Sell	3,043 -355	-10%	-$40.1K	0.11%	116
2018 Q2	$429K	Hold	3,398	–	–	0.08%	159
2018 Q1	$368K	Hold	3,398	–	–	0.07%	160
2017 Q4	$372K	Sell	3,398 -188,302	-98%	-$18.8M	0.07%	144
2017 Q3	$18.9M	Sell	191,700 -2,300	-1%	-$223K	1.25%	32
2017 Q2	$19.6M	Sell	194,000 -700	-0.4%	-$75.5K	1.3%	30
2017 Q1	$22.5M	Sell	194,700 -26,700	-12%	-$3.1M	1.47%	21
2016 Q4	$26.6M	Buy	+221,400	New	+$24.5M	1.86%	11

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International's CLB Position: Q3 2019 in Review

Capital International sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 1,709 shares — an estimated $89K sold.

Capital International first reported a position in CLB in Q4 2016 and held it in 11 quarters. The position peaked at $26.6M in Q4 2016. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Capital International reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
Capital International sold 1,709 Core Laboratories shares in Q3 2019, an estimated $89K.
Capital International first reported a position in Core Laboratories in Q4 2016 and held it in 11 quarters.
Capital International's Core Laboratories position peaked at $26.6M in Q4 2016.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Capital International's 13F filing for Q3 2019, filed 14 Nov 2019.